LEXG-Lexicon Genetics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LEXG-Lexicon Genetics

LXRX 1.250

-12.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (54)	4/29/2001 1:35:30 PM
From: Spekulatius	Read Replies (1) of 254

>> But the damage that was dealt to morale, post-02/00, is enormous. << I agree. When Biotechs get dirt cheap once in a while, waiting for a selloff to invest and selling a few weeks later seems like a very profitable investment strategy. Buy and hold was hard to beat in 1998-2000, but with the agony in the markets, it may be more profitable to look for 50% rather than 500% returns. I do like LEXG but I think that the LEXG "knockout" technology is too narrow to build a platform company. I think that LEXG would create more shareholder value after merging with another genomics tool company ( CEO's egos permitting)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next